Literature DB >> 10730301

An evaluation of modified case definitions for the detection of dengue hemorrhagic fever. Puerto Rico Association of Epidemiologists.

J G Rigau-Pérez1, G L Bonilla.   

Abstract

The case definition for dengue hemorrhagic fever (DHF) requires fever, platelets < or = 100,000/mm3, any hemorrhagic manifestation, and plasma leakage evidenced by hemoconcentration > or = 20%, pleural or abdominal effusions, hypoproteinemia or hypoalbuminemia. We evaluated the specificity and yield of modified DHF case definitions and the recently proposed World Health Organization criteria for a provisional diagnosis of DHF, using a data base of laboratory-positive and laboratory-negative reports of hospitalizations for suspected dengue in Puerto Rico, 1994 to 1996. By design, all modifications had 100% sensitivity. More liberal criteria for plasma leakage were examined: 1) adding as evidence a single hematocrit > or = 50% (specificity 97.4%); 2) accepting hemoconcentration > or = 10% (specificity 90.1%); and 3) accepting either hematocrit > or = 50% or hemoconcentration > or = 10% (specificity 88.8%). The new DHF cases identified by these definitions (and percent laboratory positive) were 25 (100.0%), 95 (90.5%), and 107 (91.6%), respectively. In contrast, the provisional diagnosis of DHF (fever and hemorrhage, and one or more of platelets < or = 100,000/mm3, or hemoconcentration > or = 20%, or at least a rising hematocrit [redefined quantitatively as a 5% or greater relative change]) showed a specificity of 66.8%, and identified 318 new DHF cases, of which 282 (88.7%) were laboratory-positive. Very small changes in the criteria may result in a large number of new cases. The modification that accepted either hematocrit > or = 50% or hemoconcentration > or = 10% had acceptable specificity, while doubling the detection of DHF-compatible, laboratory-positive severe cases, but "provisional diagnosis" showed even lower specificity, and may produce inflated DHF incidence figures. Modified case definitions should be prospectively evaluated with patients in a health-care facility before they are recommended for widespread use.

Entities:  

Mesh:

Year:  1999        PMID: 10730301

Source DB:  PubMed          Journal:  P R Health Sci J        ISSN: 0738-0658            Impact factor:   0.705


  13 in total

1.  Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005.

Authors:  Anon Srikiatkhachorn; Robert V Gibbons; Sharone Green; Daniel H Libraty; Stephen J Thomas; Timothy P Endy; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman; Suchitra Nimmannitaya; Siripen Kalayanarooj
Journal:  Clin Infect Dis       Date:  2010-04-15       Impact factor: 9.079

2.  Classification of dengue illness based on readily available laboratory data.

Authors:  James A Potts; Stephen J Thomas; Anon Srikiatkhachorn; Pra-on Supradish; Wenjun Li; Ananda Nisalak; Suchitra Nimmannitya; Timothy P Endy; Daniel H Libraty; Robert V Gibbons; Sharone Green; Alan L Rothman; Siripen Kalayanarooj
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

Review 3.  Dengue Hemorrhagic Fever at 60 Years: Early Evolution of Concepts of Causation and Treatment.

Authors:  Scott B Halstead; Sanford N Cohen
Journal:  Microbiol Mol Biol Rev       Date:  2015-09       Impact factor: 11.056

4.  Prediction of dengue disease severity among pediatric Thai patients using early clinical laboratory indicators.

Authors:  James A Potts; Robert V Gibbons; Alan L Rothman; Anon Srikiatkhachorn; Stephen J Thomas; Pra-On Supradish; Stephenie C Lemon; Daniel H Libraty; Sharone Green; Siripen Kalayanarooj
Journal:  PLoS Negl Trop Dis       Date:  2010-08-03

5.  Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndrome.

Authors:  Eduardo Villamor; Luis A Villar; Anyela Lozano-Parra; Víctor M Herrera; Oscar F Herrán
Journal:  Br J Nutr       Date:  2018-08-14       Impact factor: 3.718

6.  Evaluation of the traditional and revised WHO classifications of Dengue disease severity.

Authors:  Federico Narvaez; Gamaliel Gutierrez; Maria Angeles Pérez; Douglas Elizondo; Andrea Nuñez; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2011-11-08

7.  Dengue and dengue hemorrhagic fever, Brazil, 1981-2002.

Authors:  João Bosco Siqueira; Celina Maria Turchi Martelli; Giovanini Evelim Coelho; Ana Cristina da Rocha Simplicio; Douglas L Hatch
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

8.  Evidence and rationale for the World Health Organization recommended standards for Japanese encephalitis surveillance.

Authors:  Susan Hills; Alya Dabbagh; Julie Jacobson; Anthony Marfin; David Featherstone; Joachim Hombach; Pem Namgyal; Manju Rani; Tom Solomon
Journal:  BMC Infect Dis       Date:  2009-12-29       Impact factor: 3.090

9.  Dengue: the syndromic basis to pathogenesis research. Inutility of the 2009 WHO case definition.

Authors:  Scott B Halstead
Journal:  Am J Trop Med Hyg       Date:  2013-02       Impact factor: 2.345

10.  Vitamin D serostatus and dengue fever progression to dengue hemorrhagic fever/dengue shock syndrome.

Authors:  E Villamor; L A Villar; A Lozano; V M Herrera; O F Herrán
Journal:  Epidemiol Infect       Date:  2017-09-14       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.